The official blog of the Lung Institute.

Can Bioidentical Hormones Treat COPD?

22 Sep 2014
| Under COPD, Lung Disease, Related Conditions | Posted by | 1 Comment
Biodentical Hormones Treat COPD Lung Institute

It’s okay. That quizzical look that you have right now is pretty common when people learn about bioidentical hormones. So let’s go ahead and answer the biggest question in the room, what exactly are bioidentical hormones? The term bioidentical hormones doesn’t actually have an exact medical definition, but health experts usually define bioidentical hormones as compounds that have the same chemical and molecular structure as those produced in the human body.

Bioidentical hormones are created in a laboratory by altering compounds derived from naturally occurring plant products and are typically taken in the form of creams or gels. There has been increasing interest in recent years in the use of this type of hormone therapy for premenopausal women instead of conventional hormone therapy with synthetic hormones. Some bioidentical hormone preparations are U.S. FDA-approved and manufactured by drug companies, while others are made at special pharmacies called compounding pharmacies.

Bioidentical hormones have commonly been associated for the treatment of woman with menopause. In some cases, it has been promoted by practitioners as an anti-aging medicine—although there is little information if this actually works. In the last few years though, bioidentical hormones have been researched to see if this application can be adapted for the treatment of other diseases, including chronic obstructive pulmonary disease (COPD). So, can bioidentical hormones treat COPD?

What Does Research Say About Bioidentical Hormones Treating COPD?

COPD is a progressive form of lung disease ranging from mild to severe. It is characterized by a restriction of airflow into and out of the lungs that makes breathing difficult. COPD is the umbrella term for sufferers who have been diagnosed with or show signs of emphysema and/or chronic bronchitis. So does this treatment help with patients with COPD?

According to an article published online, bioidentical hormone replacement therapy (BHRT) was actually used to see if lung function/tissue could be healed with a boost in estrogen. The study was only used on female rats that had both issues with low estrogen and severe lung damage. Researchers discovered that there was a difference in the rats that were supplied with bioidentical hormones compared to the female rats that did not. The rats that were provided with the hormones showed improved estrogen levels and a recovery in some lung function. The study goes on to say that there is a direct correlation in woman with low estrogen and lung diseases like COPD.

While some bioidentical hormones are approved by the FDA, more research is needed to understand the use of this application on patients with COPD. If you or a loved one has been diagnosed with lung disease such as COPD and want to learn more about treatment options, please contact or call (800) 729-3065 today.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.